Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
The overall average breast cancer incidence rate in the U.S. was 131.8 per 100,000 and the overall average breast cancer mortality rate was 19.3 per 100,000. Among women in the U.S., breast cancer ...
5don MSN
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine ...
Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study from Germany featuring over 461,000 women.
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...
CDK4/6 inhibitors like abemaciclib and ribociclib improve invasive disease-free survival in breast cancer trials, but controversy surrounds study designs, bias, and cost-effectiveness, raising ...
HealthDay on MSN11d
Exercise Prior to Cancer Diagnosis May Help Slow Disease ProgressionEven low levels of exercise provided protection against cancer, a new study published Jan. 7 in the British Journal of Sports ...
Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback